| Eisai Pharma AG - Fycompa 0.5 mg / mL, Suspension zum Einnehmen | | 67665 | | 01 | | Fycompa 0.5 mg / mL | | Suspension zum Einnehmen | | N03AX22 | | Perampanel | | 16.04.2020 | | |
| | Composition | | perampanelum anhydricum 0.5 mg, sorbitolum liquidum cristallisabile corresp. sorbitolum 175 mg, cellulosum microcristallinum, carmellosum natricum, poloxamerum 188, dimeticonum, polysorbatum 65, methylcellulosum, silica colloidalis hydrica, macrogoli stearas, E 210 < 0.005 mg, E 200, acidum sulfuricum, acidum citricum, E 211 1.1 mg, aqua purificata q.s. ad suspensionem pro 1 ml corresp. natrium max. 0.474 mg. | | Packungsbestandteile | | Suspension (orale) | | | | | | Principe actif | Concentr. |
|---|
| Perampanelum Anhydricum | 0.5 mg/ml |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Acide Citrique | | | | Acide Sulfurique | | | | Aqua Purificata | | | | Carmellose Sodique | | | | Cellulosum Microcristallinum | | | | Dimeticone | | | | E 200 | | conserv. | | E 211 | 1.1 mg/ml | conserv. | | Macrogoli Stearas | | | | Methylcellulosum | | | | Poloxamer | 188 | | | Polysorbatum 65 | | | | Silica Colloidalis Hydrica | | | | Sorbitolum Liquidum Cristallisabile | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 340 ml | DDP | DDP | B | | Oui |
|
|
